Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery

Oct.12.2024
Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
A new Innokin Trine e-cigarette with replaceable battery has hit shelves in Europe, meeting upcoming EU regulations.

Recently, 2Firsts noticed a new type of replaceable battery e-cigarette called the Innokin Trine being showcased at a tobacco exhibition in Dortmund. The product, launched by e-cigarette brand Innokin, is now available on e-cigarette retail websites in regions such as the UK and Germany. With its design allowing for replaceable batteries, the product complies with the new regulations set to be implemented by the EU Battery Directive in 2026.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Innokin Trine displayed at the tobacco exhibition in Dortmund by Innokin|Image source: 2Firsts


At the recent Dortmund tobacco exhibition, several exhibitors showcased e-cigarette products with replaceable batteries, including disposable, pod-based, and open-system devices, in response to the EU's Battery Directive. According to the directive, by 2026, batteries in portable devices (such as disposable e-cigarettes) must be easily removable and replaceable by the user.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image Source | Innokin Official Website


The newly released Innokin Trine, an open system product from Innokin, complies with the upcoming new regulations in the European Union market.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin official website


In addition, the main feature of Trine is its "three-in-one" structure: atomizer, detachable and rechargeable battery, control panel. At the same time, the detachable and rechargeable battery enhances the convenience and durability of the device.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin brand official website


Specifically, the main product features of the Innokin Trine include:


E-liquid capacity: 2ml Nicotine concentration: Supports a variety of nicotine levels in e-liquid Battery capacity: 1000mAh removable battery Charging method: Supports Type-C fast charging.


Trine Power Hub charger charges


Backup batteries can also be purchased separately.


Power Mode: Provides a power output of 6-25W.


Function: - Suction activation


Support mouth to lung (MTL) or limit direct lung (RDL) inhale mode.


Compatible with a variety of e-liquid flavors.


Charging indicator light


The screen displays operational parameters such as output power and battery level.


Currently, the Innokin Trine has been listed on the official website of the Innokin e-cigarette brand and major distributor websites in Europe, with a selling price of approximately 19.95 euros.


In addition to the Innokin brand, other brands such as GOLISI and NEXIONE have also introduced similar products with replaceable batteries. 2Firsts will continue to monitor the latest products and market trends in replaceable battery e-cigarette products, providing the public with accurate and authoritative industry information.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives